FDA Investigator Robert W Calais
Robert W Calais has inspections in 13 countries as of 01 Nov 2023. Robert W Calais has collaborated with a combined 3218 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
161
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
Viet Nam,
United States of America,
Spain,
Italy,
Argentina,
Poland,
Thailand,
United Kingdom of Great Britain and Northern Ireland,
France,
Iceland,
Switzerland
Co-Investigator(s):
Aaron F Coleman,
Albert A Salvador,
Alec D Fabus,
Alec M O'neal,
Andrew I Carr,
Andrew J Mcguffin,
Angela F Orozco,
Antoinette L Ravelli,
Ashley A Mutawakkil,
Ashley A Segura,
Ashley B Jelonek,
Ashley Gonzalez,
Barbara T Carmichael,
Benita C Okeke,
Betsy C Galliher,
Bill Tacket, Jr,
Brandi L Garbutt,
Brant M Schroeder,
Brian M Palermo,
Brian R Yaun,
Brian Ravitch,
Brunilda Torres,
Carol A Perry,
Carol A Robles,
Cary Greene,
Charles N Dupont,
Charles S Watson,
Cheryl G Scott,
Christian L Witkovskie,
Claire M Minden,
Clara E Santiago,
Clausnitzer,
Craig P Seaborn,
Daniel W Johnson,
Darcy L Webber,
Dariusz Galezowski,
David P King,
Deborah A Racioppi,
Deborah K Richardson,
Decima L Thompson,
Devon Jenkins,
Dhaval H Patel,
Diana L Kelsch,
Dillard H Woody, Jr,
Dionne D Arline,
Donald J Mee,
Doreen P Gubbay,
Eduardo Carbonell,
Edward Oshaughnessy,
Edwards,
Elizabeth P Mayer,
Ernest A Clausnitzer,
Ernest L Levins,
Glenn S Quintanilla,
Gobiga Vanniyasingam,
Harry R Bringger, Jr,
Herbert M Corbello,
Herrmann,
Holly M Scott,
Hunt,
Israel Juarbe,
James P Stallings,
Jamie I Espinosa,
Jana L Caylor,
Janaye A Young,
Jasmine M Rueda Fabre,
Jason D Tenney,
Jason P Aun,
Jennifer A Bazergui,
Jennifer A Robinson,
Jennifer Caycedo,
Jennifer L Huntington,
Jesse Ray N Nardone,
Jessica L Pressley,
Jessica M Monteiro,
Jo Annc Declement,
John B Crowe,
Jose N Santiago,
Jose Perez Soto,
Jose R Rodriguez,
Joshua C Schafer,
Joy Rkozlowski Klena,
Juan C Gonzalez Rivera,
Judith A Jones,
Judith A Paterson,
Karen A Spencer,
Karen F Tomaziefski,
Karissa J Mccaw,
Karl D Hezel,
Keith A Schwartz,
Kelly I Anderson,
Kenitra D Hewitt,
King,
Krystyna M Kitson,
Kyle D Covill,
Ladislav Kermet,
Laura B Kennedy,
LCDR Michael H Tollon,
LCDR Randall L Morris,
Leo J Lagrotte,
Leroy Terrelonge,
Leslie A Cartmill,
Leslie A Jackanicz,
Lilly O Barton,
Linda K Matheny,
Lindsay R Hatch,
Lindsay R Mundy,
Lisa A Warner,
Lisa Harlan,
Lissette Paiz,
LT Daveta L Bailey,
LT Kimberly M Hull,
Lura D Kelly,
Madelyn Renteria,
Marcelo O Mangalindan, Jr,
Matthew B Thomaston,
Megan E Kulas,
Melanie G Warzala,
Melinda L Rice,
Melissa B Libby,
Melissa J Hill,
Mendoza,
Meredith L Sheridan,
Meredith M Cobb,
Michael C Lombardi,
Michael E Campbell,
Michael Rosner,
Munoz,
Nancy M Espinal,
Nelson E Venerio,
Nicolas Riveratorres,
Nicole E Knowlton,
Nicole M Bell,
Nympha V Florendo,
Ormond,
Osama M Hamoud,
Paterson,
Patrick J Legler,
Pedro A Cruz,
Quynh H Strandberg,
Ramanda C Gregory,
Raymond Cheung,
Raymond L Cheung,
Regina T Brown,
Remache,
Rene M Amaguana,
Reynolds,
Richard D Manney,
Richard K Vogel,
Rina Bhikha,
Robert C Coleman,
Robert D Ogan,
Robert J Goldman,
Robert J Martin,
Rodney W Lenger,
Ronald T Colucci,
Ruth A Williams,
Salvatore N Randazzo,
Samantha J Pinizzotto, D V M,
Sands,
Sarah K Graham,
Schultz,
Sean D Duke,
Seng Ching Hwang,
Shelton L Stribling,
Sonia D Hudson,
Sonia M Monges,
Stacey F Allard,
Stacey F Rivette,
Stacey L Witherwax,
State Agency,
Stephanie C Milan,
Stephanie T Durso,
Stephen J Mottola,
Susan M Turcovski,
Tegan M Vanartsdalen,
Teigan M Mule,
Teresa M Hillebrandt,
Thomas Cote,
Thomas J Hudson,
Tracy L Reed,
Vernon L O'neil,
Wayne J Meyer,
Wayne L Jefferson,
William J Muszynski,
William W Dotts,
Woody
Robert W Calais's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2021 | FDA 483 | CerBurg Products Ltd. - Form 483, 2021-09-17 |
October, 2021 | EIR | RCBA Nutraceuticals LLC - EIR, 2021-10-06 |
September, 2021 | EIR | CerBurg Products Ltd. - EIR, 2021-09-17 |
February, 2018 | FDA 483 | Peace River Citrus Products, Inc. - Form 483, 2018-02-20 |
June, 2022 | FDA 483 | NNS Organics Limited - Form 483, 2022-06-09 |
September, 2022 | FDA 483 | AZACONSA S.L. - Form 483, 2022-09-22 |
January, 2016 | EIR | Bravo Packing, Inc. - EIR, 2016-01-28 |
February, 2018 | EIR | Peace River Citrus Products, Inc. - EIR, 2018-02-20 |
October, 2015 | EIR | Southport Distribution, LLC - EIR, 2015-10-16 |
February, 2017 | EIR | Bravo Packing, Inc. - EIR, 2017-02-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more